In 2015, Kirkland & Ellis partners Amanda Hollis and Steven Cherny won a rare preliminary injunction for their clients C.R. Bard Inc. and Davol Inc. barring sales of CryoLife Inc.’s competitive blood-clotting product. The judge called the injunction an “extraordinary” remedy. That word also captures the successes of the firm’s Chicago intellectual property practice team in the past year.
How does the 55-member team do it? “Let’s start with an extraordinarily talented group,” said partner and team member Luke Dauchot. “It’s not only talented from a legal perspective but pragmatic as well — meaning the group understands that litigation is not an end to itself; the clients’ business goals are the end.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
